Xstrahl would like to invite you to join them in targeting optimal care at ESTRO 38, 26th-30th April 2019 in Milan, Italy. Xstrahl is launching the new Xstrahl 150 at the event, its fully redesigned and improved 150kV X-ray therapy system for treating skin cancers. A...
The radiopharmaceutical (131)I-meta-iodobenzylguanidine ((131)I-MIBG) is an effective treatment for neuroblastoma. However, maximal therapeutic benefit from (131)I-MIBG is likely to be obtained by its combination with chemotherapy. In a previous paper by Nile DL, Rae...
Low dose radiation therapy is the typical treatment for elderly patients aged ≥70 years, for painful benign skeletal disorders such as calcaneodynia, achillodynia, painful gonarthrosis, and painful bursitis trochanterica. However the short- and long-term efficacy has...
The main objective of radiobiology is to establish links between doses and radiation-induced biological effects. In this context, well-defined dosimetry protocols are crucial to the determination of experimental protocols. In their paper “Importance of dosimetry...
Knee bone marrow edema is often diagnosed with the help of MRI as a consequence of trauma, overload, surgery, arthrosis or osteonecrosis. One of its most common reasons is cruciate ligament rupture surgery. The edema pathogenesis is not known for sure. The bone marrow...
Despite a major paradigm shift in radiotherapy planning and delivery over the past three decades with continuing refinements, radiation-induced lung damage (RILD) remains a major dose limiting toxicity in patients receiving thoracic irradiations. Our current...
Although small animal image-guided radiotherapy (SA-IGRT) systems are used increasingly in preclinical research, tools for performing routine quality assurance have not been optimized and are not readily available. Robust, efficient, and reliable quality assurance...
OBJECTIVE Non-ablative or mild hyperthermia (HT) has been shown in preclinical (and clinical) studies as a localized radiosensitizer that enhances the tumoricidal effects of radiation. Most preclinical in vivo HT studies use subcutaneous tumor models which do not...
February 28th, 2019 – Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is spotlighting its RADiant treatment system at the American Academy of Dermatology (AAD) annual meeting in...
Contact Us